Zhujiang Hospital of Southern Medical University
Guangzhou, Guangdong, 510280, China
Location status: Recruiting
NCT Number: NCT06082284
By using a highly sensitive serum M protein detection method based on the MALDI-TOF MS platform, serum monoclonal immunoglobul (M protein) in detection was performed on the visiting patients to explore the positive rate of serum M protein and its distribution in different departments. And exploring the correlation analysis between the relative concentration of serum M protein based on the above highly sensitive methods and clinical indicators.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Guangzhou, Guangdong, 510280, China
Location status: Recruiting
Monoclonal gammopathy (MG) is an asymptomatic pre-cancerous clonal proliferation of plasma cells. The onset of this disease is concealed, usually discovered by chance by patients who undergo protein electrophoresis to detect monoclonal gamma globulin (M protein) due to various clinical symptoms and disease evaluations. Due to the insidious onset of monoclonal immunoglobulin, involving multiple organs, and the non-specific clinical symptoms, it is more prone to misdiagnosis. This study hypothesized that among patients who first came to the hospital for treatment, some patients had elevated serum monoclonal immunoglobulin levels but were not initially diagnosed with hematology department, but instead sought medical attention from other departments due to other symptoms. In this study,by using a highly sensitive serum M protein detection method based on the MALDI-TOF MS platform, serum monoclonal immunoglobul (M protein) in detection was performed on the visiting patients to explore the positive rate of serum M protein and its distribution in different departments,and to explore the correlation analysis between the relative concentration of serum M protein based on the above highly sensitive methods and clinical indicators.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: one year
Positive rate of serum M protein in patients seeking medical treatment at the hospital
Time frame: one year
The positive rate of serum M protein in the patients visiting the hospital and its distribution in different departments.
Time frame: one year
Correlation analysis between the relative concentration of serum M protein and clinical indicators.
Contact information is provided by the study sponsor or research team.
Zhujiang Hospital
Other
A Cross-sectional Study on the Positive Rate of Monoclonal Immunoglobulin (M Protein) in the Serum of Patients Seeking Medical Treatment in Tertiary Hospitals Based on a Highly Sensitive Serum M Protein Detection Method.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07285044
Adenocarcinoma, Adnexal Diseases
Jacksonville, Florida, United States
View Trial DetailsNCT01676805
Blood Protein Disorders, Cardiovascular Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT07652281
Blood Protein Disorders, Cardiovascular Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT06207799
Blood Protein Disorders, Cardiovascular Diseases
Houston, Texas, United States
View Trial Details